Načítá se...

NEW AND EMERGING DEVELOPMENTS IN EXTENSIVE STAGE SMALL CELL LUNG CANCER THERAPEUTICS

PURPOSE OF REVIEW: Extensive-stage small cell lung cancer (SCLC) remains a disease with a dismal prognosis, with median survival of approximately 8–10 months. Despite many attempts to develop effective systemic therapies, very little progress has been made in the last several decades. Platinum-based...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Opin Oncol
Hlavní autoři: Parikh, Mamta, Riess, Jonathan, Lara, Primo N.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139911/
https://ncbi.nlm.nih.gov/pubmed/26844984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000264
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!